Menard Financial Group’s Idexx Laboratories IDXX Stock Holding History

Menard Financial Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-110	Closed	-$45.5K	–	184
2024 Q4	$45.5K	Buy	+110	New	+$48.2K	0.03%	189

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Menard Financial Group's IDXX Position: Q1 2025 in Review

Menard Financial Group sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 110 shares — an estimated $45.5K sold.

Menard Financial Group first reported a position in IDXX in Q4 2024 and held it in 1 quarter. The position peaked at $45.5K in Q4 2024. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

Menard Financial Group reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
Menard Financial Group sold 110 Idexx Laboratories shares in Q1 2025, an estimated $45.5K.
Menard Financial Group first reported a position in Idexx Laboratories in Q4 2024 and held it in 1 quarter.
Menard Financial Group's Idexx Laboratories position peaked at $45.5K in Q4 2024.
1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Menard Financial Group's 13F filing for Q1 2025, filed 8 May 2025.